The Genetic And Morphological Evaluation (GAME) score was utilized to risk stratify patients based on KRAS status, carcinoembryonic antigen levels, primary tumor lymph node metastasis, tumor burden score, and extrahepatic disease. This evidence concerns the gene KRAS and neoplasm.